[Form 4] Axon Enterprise, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Axon Enterprise insider sales by CPO & CTO Jeffrey C. Kunins: The filing shows Mr. Kunins disposed of a total of 11,891 shares between 08/13/2025 and 08/14/2025, including 5,122 shares withheld to satisfy taxes on vested restricted stock units and multiple open-market sales executed under a Rule 10b5-1 trading plan adopted March 10, 2025. Share sale prices reported as weighted averages range from about $746.62 to $753.77 across the trades. Following these transactions, the reporting person’s beneficial ownership decreased from 152,429 to 144,538 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025.

Positive

• Sales executed under a documented Rule 10b5-1 plan, indicating trades were prearranged and not opportunistic
• Tax-withholding on RSU vesting disclosed, showing standard compensation-related disposition

Negative

• Insider beneficial ownership decreased from 152,429 to 144,538 shares, a reduction of 7,891 shares (approximate 5.2% decrease)
• Multiple open-market sales over 08/14/2025 totaling 6,769 shares that may be interpreted by some investors as insider selling pressure

Insights

Securities Analyst

TL;DR: Routine tax withholding and planned sales reduced insider holdings by ~7.8%, executed under a pre-established 10b5-1 plan.

The transactions are a mix of tax-withholding related disposition and scheduled open-market sales pursuant to a 10b5-1 plan adopted March 10, 2025. The initial 5,122-share disposition was to satisfy tax liabilities from RSU vesting; subsequent sales totaling 6,769 shares were reported across multiple trades with weighted-average prices disclosed by trade group. From an investor-impact perspective this filing is informational rather than a material corporate event, as no new company-specific operational or financial information is disclosed.

Corporate Governance Expert

TL;DR: Disclosure aligns with SEC rules: tax-related withholding and an executed 10b5-1 plan; no governance concerns disclosed.

The Form 4 indicates the reporting person used an established Rule 10b5-1 plan for sales and documented tax-withholding on vested RSUs. The filer provided price ranges and committed to supply trade-level details on request, consistent with transparent disclosure practice. There are no indications in the filing of unscheduled, ad hoc insider trading or departures from standard reporting protocols.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunins Jeffrey C

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CPO & CTO

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		F(1)		5,122	D	$765.52	152,429	D
Common Stock	08/14/2025		S(2)		900	D	$746.961(3)	151,529	D
Common Stock	08/14/2025		S(2)		1,000	D	$748.4776(4)	150,529	D
Common Stock	08/14/2025		S(2)		2,368	D	$749.7832(5)	148,161	D
Common Stock	08/14/2025		S(2)		1,954	D	$750.7305(6)	146,207	D
Common Stock	08/14/2025		S(2)		1,000	D	$751.7973(7)	145,207	D
Common Stock	08/14/2025		S(2)		369	D	$752.9806(8)	144,838	D
Common Stock	08/14/2025		S(2)		200	D	$753.67(9)	144,638	D
Common Stock	08/14/2025		S(2)		100	D	$754.73	144,538	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.

2. This sale of shares, received upon settlement of vested restricted stock units, was executed pursuant to a filed Rule 10b5-1 plan adopted by the reporting person on March 10, 2025.

3. The transaction was executed in multiple trades at prices ranging from $746.62 to $747.22. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. The transaction was executed in multiple trades at prices ranging from $748.07 to $748.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. The transaction was executed in multiple trades at prices ranging from $749.16 to $750.12. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. The transaction was executed in multiple trades at prices ranging from $750.28 to $751.19. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. The transaction was executed in multiple trades at prices ranging from $751.32 to $752.20. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. The transaction was executed in multiple trades at prices ranging from $752.525 to $753.34. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

9. The transaction was executed in multiple trades at prices ranging from $753.57 to $753.77. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Jeffrey C. Kunins, by Isaiah Fields, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AXON insider Jeffrey Kunins report on Form 4?

The filing reports dispositions totaling 11,891 shares between 08/13/2025 and 08/14/2025, including 5,122 shares withheld for taxes and additional open-market sales under a Rule 10b5-1 plan.

Were the 08/14/2025 sales at AXON (AXON) spontaneous or preplanned?

The sales on 08/14/2025 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2025.

How much did the reporting person own after these transactions?

Following the reported transactions the reporting person beneficially owned 144,538 shares.

What prices were the AXON shares sold at in these transactions?

Reported weighted-average prices by trade group ranged from approximately $746.62 to $753.77; the Form 4 provides price ranges and weighted averages per transaction group.

Was any of the share disposition related to compensation tax obligations?

Yes, 5,122 shares were disposed to satisfy the reporting person’s tax liability arising from the vesting of restricted stock units.